Eugeni Bonet-Lopez

Girona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Mitochondrial priming and response to BH3 mimetics in "one-two punch" senogenic-senolytic strategies.

Mitochondrial priming and response to BH3 mimetics in "one-two punch" senogenic-senolytic strategies.

Journal: Cell death discovery

Published: August 12, 2024

Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity.

Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity.

Journal: Cell death discovery

Published: July 04, 2024

Silibinin is a suppressor of the metastasis-promoting transcription factor ID3.

Silibinin is a suppressor of the metastasis-promoting transcription factor ID3.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: November 21, 2023

Highly Sensitive Microsatellite Instability and Immunohistochemistry Assessment in Endometrial Aspirates as a Tool for Cancer Risk Individualization in Lynch Syndrome.

Highly Sensitive Microsatellite Instability and Immunohistochemistry Assessment in Endometrial Aspirates as a Tool for Cancer Risk Individualization in Lynch Syndrome.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: September 21, 2022

DigiPatICS: Digital Pathology Transformation of the Catalan Health Institute Network of 8 Hospitals-Planification, Implementation, and Preliminary Results.

DigiPatICS: Digital Pathology Transformation of the Catalan Health Institute Network of 8 Hospitals-Planification, Implementation, and Preliminary Results.

Journal: Diagnostics (Basel, Switzerland)

Published: February 20, 2022

Prognostic significance of the microbiome-adipose tissue axis in rectal cancer: protocol of a prospective observational study.

Prognostic significance of the microbiome-adipose tissue axis in rectal cancer: protocol of a prospective observational study.

Journal: BJS open

Published: December 07, 2021

Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in Girona.

Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in Girona.

Journal: International journal of environmental research and public health

Published: October 15, 2021

Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer.

Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer.

Journal: Cancers

Published: July 13, 2021

Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer.

Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer.

Journal: Journal of clinical medicine

Published: November 07, 2019

Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity.

Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity.

Journal: Aging

Published: August 09, 2019

Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients.

Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients.

Journal: Aging

Published: April 01, 2019

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin.

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin.

Journal: Frontiers in oncology

Published: December 18, 2018

Showing 1-12 of 30

Last Updated: 09/26/2026